| GTG Stock | | | 0.04 0.00 0.00% |
Genetic Technologies financial indicator trend analysis is much more than just examining Genetic Technologies latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genetic Technologies is a good investment. Please check the relationship between Genetic Technologies Non Current Assets Total and its Total Stockholder Equity accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Non Current Assets Total vs Total Stockholder Equity
Non Current Assets Total vs Total Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Genetic Technologies Non Current Assets Total account and
Total Stockholder Equity. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Genetic Technologies' Non Current Assets Total and Total Stockholder Equity is 0.12. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Genetic Technologies, assuming nothing else is changed. The correlation between historical values of Genetic Technologies' Non Current Assets Total and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Genetic Technologies are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Non Current Assets Total i.e., Genetic Technologies' Non Current Assets Total and Total Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.12 |
| Relationship Direction | Positive |
| Relationship Strength | Insignificant |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Genetic Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genetic Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
At this time, Genetic Technologies'
Selling General Administrative is comparatively stable compared to the past year.
Tax Provision is expected to grow at the current pace this year, whereas
Issuance Of Capital Stock is likely to drop slightly above 2.2
M in 2025.
Genetic Technologies fundamental ratios Correlations
Click cells to compare fundamentals
Genetic Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Genetic Technologies fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Genetic Stock Analysis
When running Genetic Technologies' price analysis, check to
measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to
predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.